SCHEMBL3002913

SCHEMBL3002913

CCOC(=O)Cc1nnnn1C1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
LMNA P02545 2/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
USP2 O75604 3/20 0.44
HSD11B1 P28845 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK1 P28482 2/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
PKM P14618 1/20 0.40
ATM Q13315 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPBWR1 P48145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27808986 0.84 ALDH1A1 (0.46) ALDH1A1MAPTTP53LMNAKMT2A
SCHEMBL1975157 0.79 L3MBTL1 (0.56) ALDH1A1MAPTTP53LMNAKMT2A
SCHEMBL3093471 0.79 ALDH1A1 (0.46) ALDH1A1MAPTTP53LMNAKMT2A
SCHEMBL3300574 0.78 L3MBTL1 (0.58) ALDH1A1MAPTTP53KMT2AMEN1
SCHEMBL18623454 0.77 LMNA (0.46) ALDH1A1LMNAKMT2AMEN1L3MBTL1
SCHEMBL3452952 0.74 MAPK1 (0.50) ALDH1A1MAPK1RAB9APKMATM
SCHEMBL15014082 0.74 ALDH1A1 (0.63) ALDH1A1MAPTTP53LMNAKMT2A
SCHEMBL18646759 0.73 MAPK1 (0.57) ALDH1A1LMNAKMT2AMEN1MAPK1
SCHEMBL10703847 0.73 MAPK1 (0.49) ALDH1A1MAPK1RAB9APKMATM
SCHEMBL10683958 0.73 ALDH1A1 (0.45) ALDH1A1MAPTTP53LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173925-A1 OXYINDOLE DERIVATIVES PFIZER INC 2010-07-08 US disclosed
US-7589109-B2 Oxyindole derivatives PFIZER INC (US) 2009-09-15 US disclosed
EP-1856110-A1 OXYINDOLE DERIVATIVES AS 5HT4 RECEPTOR AGONISTS Pfizer, Inc. (US) 2007-11-21 EP disclosed
US-20060194842-A1 Oxyindole derivatives PFIZER INC. 2006-08-31 US disclosed
WO-2006090279-A1 OXYINDOLE DERIVATIVES AS 5HT4 RECEPTOR AGONISTS PFIZER JAPAN INC. (JP) 2006-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173925-A1 OXYINDOLE DERIVATIVES HTR4, HTR5A, HRH4 ALDH1A1 2553/4885MAPT 972/4885TP53 4424/4885
US-20060194842-A1 Oxyindole derivatives HTR4, HTR5A, HRH4 ALDH1A1 2553/4885MAPT 972/4885TP53 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.